BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7238762)

  • 1. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
    Goodnick PJ; Meltzer HY
    J Clin Psychopharmacol; 1983 Aug; 3(4):239-43. PubMed ID: 6411776
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sleep deprivation on dopamine receptor function in normal subjects.
    Lal S; Thavundayil J; Nair NP; Etienne P; Rastogi R; Schwartz G; Pulman J; Guyda H
    J Neural Transm; 1981; 50(1):39-45. PubMed ID: 7205248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.
    Whalley LJ; Christie JE; Brown S; Arbuthnott GW
    Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine: chemistry, pharmacology, biochemistry.
    Colpaert FC; Van Bever WF; Leysen JE
    Int Rev Neurobiol; 1976; 19():225-68. PubMed ID: 13044
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
    Lal S; De la Vega CE; Sourkes TL; Friesen HG
    J Clin Endocrinol Metab; 1973 Nov; 37(5):719-24. PubMed ID: 4749446
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY; Lee MA; Jayathilake K
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Young SN; Cervantes P; Guyda H
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man.
    Tolis G; Hickey J; Guyda H
    J Clin Endocrinol Metab; 1975 Oct; 41(4):797-800. PubMed ID: 1176587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.